We are live on ! Find out more
NEO icon

NeoGenomics

274 hedge funds and large institutions have $930M invested in NeoGenomics in 2025 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 97 increasing their positions, 67 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

270% more call options, than puts

Call options by funds: $9.57M | Put options by funds: $2.59M

55% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 38

45% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 67

7% more funds holding

Funds holding: 256274 (+18)

0.46% more ownership

Funds ownership: 98.33%98.79% (+0.46%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

23% less capital invested

Capital invested by funds: $1.2B → $930M (-$270M)

Holders
274
Holders Change
+18
Holders Change %
+7.03%
% of All Funds
3.61%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
59
Increased
97
Reduced
67
Closed
38
Calls
$9.57M
Puts
$2.59M
Net Calls
+$6.98M
Net Calls Change
-$2.05M

NEO Hedge Fund Activity: Q2 2025 in Review

274 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2025, worth a combined $930M — down 23% from $1.2B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new NEO positions and 38 closed out — a net gain of 21 holders — while 97 added to existing stakes and 67 trimmed.

The largest buyer was Greenhouse Funds, adding an estimated $22M. The largest seller was Brown Advisory, exiting entirely with an estimated $36.7M sold.

  • 274 institutional investors held NeoGenomics (NEO) as of Q2 2025, up from 256 in Q1 2025.
  • Funds reported $930M of NeoGenomics stock for Q2 2025, down 23% quarter-over-quarter.
  • 59 funds opened new NeoGenomics positions in Q2 2025 and 38 closed out, a net change of +21 holders.
  • The largest NeoGenomics buyer in Q2 2025 was Greenhouse Funds, an estimated $22M added.
  • The largest NeoGenomics seller in Q2 2025 was Brown Advisory, an estimated $36.7M sold.

Based on aggregated 13F filings for Q2 2025.